• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非典型甲状旁腺腺瘤的基因改变图谱及临床病理相关性

Genetic Alteration Profiles and Clinicopathological Associations in Atypical Parathyroid Adenoma.

作者信息

Mao Xinxin, Wu Yan, Yu Shuangni, Chen Jie

机构信息

Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Shuai Fu Yuan Hu Tong, Beijing 100730, China.

出版信息

Int J Genomics. 2021 Mar 9;2021:6666257. doi: 10.1155/2021/6666257. eCollection 2021.

DOI:10.1155/2021/6666257
PMID:33778063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7969847/
Abstract

Genomic aberrations associated with atypical parathyroid adenoma (AA) are poorly understood. Thus, herein, we sought to expand our current understanding of the molecular basis of atypical parathyroid adenomas. We analyzed 134 samples that had been surgically obtained from parathyroid tumors, including parathyroid carcinomas, atypical parathyroid adenomas, and parathyroid adenomas. The tumors were harvested from formalin-fixed, paraffin-embedded tissues. Fifteen tumor-related genes from recently published genome sequencing data were subjected to targeted sequencing analysis, and an average sequencing depth of 500x was achieved. Sixteen (16/50, 32%) AA tumors harbored at least one of the following genomic alterations: (12, 24%), (4, 8%), (1, 2%), and (1, 2%). Our study identified, for the first time, a relatively high frequency of genomic alterations in patients with AA in a Chinese population. This suggests that AA arises , rather than developing from a parathyroid adenoma. Altogether, these findings will improve our understanding of the malignant potential of parathyroid tumors at the molecular level.

摘要

与非典型甲状旁腺腺瘤(AA)相关的基因组畸变目前了解甚少。因此,在本文中,我们试图拓展对非典型甲状旁腺腺瘤分子基础的现有认识。我们分析了134例通过手术获取的甲状旁腺肿瘤样本,包括甲状旁腺癌、非典型甲状旁腺腺瘤和甲状旁腺腺瘤。这些肿瘤取自福尔马林固定、石蜡包埋的组织。对最近发表的基因组测序数据中的15个肿瘤相关基因进行靶向测序分析,平均测序深度达到500倍。16例(16/50,32%)AA肿瘤存在以下至少一种基因组改变: (12例,24%)、 (4例,8%)、 (1例,2%)和 (1例,2%)。我们的研究首次在中国人群中发现AA患者基因组改变的频率相对较高。这表明AA是 发生的,而非由甲状旁腺腺瘤发展而来。总之,这些发现将在分子水平上增进我们对甲状旁腺肿瘤恶性潜能的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cddc/7969847/601156844395/IJG2021-6666257.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cddc/7969847/d775a33153c9/IJG2021-6666257.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cddc/7969847/601156844395/IJG2021-6666257.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cddc/7969847/d775a33153c9/IJG2021-6666257.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cddc/7969847/601156844395/IJG2021-6666257.002.jpg

相似文献

1
Genetic Alteration Profiles and Clinicopathological Associations in Atypical Parathyroid Adenoma.非典型甲状旁腺腺瘤的基因改变图谱及临床病理相关性
Int J Genomics. 2021 Mar 9;2021:6666257. doi: 10.1155/2021/6666257. eCollection 2021.
2
A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations.携带杂合种系CDC73突变的甲状旁腺腺瘤和癌的比较基因组分析
J Clin Endocrinol Metab. 2025 Jan 21;110(2):429-440. doi: 10.1210/clinem/dgae506.
3
Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas.复发性和转移性甲状旁腺癌潜在分子治疗靶点的初步探索。
Int J Cancer. 2019 Feb 1;144(3):525-532. doi: 10.1002/ijc.31948. Epub 2018 Dec 3.
4
EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.EZH2和ZFX癌基因在甲状旁腺肿瘤恶性行为中的作用
Endocrine. 2016 Oct;54(1):55-59. doi: 10.1007/s12020-016-0892-y. Epub 2016 Feb 15.
5
Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.非典型甲状旁腺腺瘤:内分泌肿瘤鉴别诊断中的具有挑战性病变。
Endocr Relat Cancer. 2019 Jul;26(7):R441-R464. doi: 10.1530/ERC-19-0135.
6
Defining a molecular phenotype for benign and malignant parathyroid tumors.定义良性和恶性甲状旁腺肿瘤的分子表型。
Cancer. 2009 Jan 15;115(2):334-44. doi: 10.1002/cncr.24037.
7
Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.抑癌基因 1 (HIC1)在甲状旁腺肿瘤中通过组蛋白 H3 赖氨酸修饰而发生表观遗传学失调控。
J Clin Endocrinol Metab. 2012 Jul;97(7):E1307-15. doi: 10.1210/jc.2011-3136. Epub 2012 Apr 27.
8
Deoxyribonucleic acid cytometry helps identify parathyroid carcinomas.脱氧核糖核酸细胞计数法有助于识别甲状旁腺癌。
J Clin Endocrinol Metab. 1988 Oct;67(4):779-84. doi: 10.1210/jcem-67-4-779.
9
Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis.甲状旁腺肿瘤:临床、组织病理学及基于组织芯片的分子分析
Hum Pathol. 2003 Jan;34(1):54-64. doi: 10.1053/hupa.2003.55.
10
Immunohistochemical Analysis of the Cell Cycle-Associated Antigens Ki-67 and Retinoblastoma Protein in Parathyroid Carcinomas and Adenomas.甲状旁腺癌和腺瘤中细胞周期相关抗原Ki-67和视网膜母细胞瘤蛋白的免疫组织化学分析
Endocr Pathol. 1995 Winter;6(4):279-287. doi: 10.1007/BF02738728.

引用本文的文献

1
Primary exploration of cell-free DNA in the plasma of patients with parathyroid neoplasms using next-generation sequencing.使用下一代测序技术对甲状旁腺肿瘤患者血浆中的游离DNA进行初步探索。
Cancer Cell Int. 2025 Mar 12;25(1):86. doi: 10.1186/s12935-025-03699-w.
2
Patterns and Predictors of Cervical Lymph Node Metastasis in Parathyroid Carcinoma.甲状旁腺癌颈部淋巴结转移的模式及预测因素
Cancers (Basel). 2022 Aug 19;14(16):4004. doi: 10.3390/cancers14164004.
3
Parathyroid Crisis as Presentation of Atypical Parathyroid Adenoma: Two Diagnostically Challenging Cases.

本文引用的文献

1
Multiple Endocrine Neoplasia Type 1 (MEN1) Phenocopy Due to a Cell Cycle Division 73 () Variant.由于细胞周期分裂73()变体导致的1型多发性内分泌肿瘤(MEN1)表型模拟
J Endocr Soc. 2020 Sep 26;4(11):bvaa142. doi: 10.1210/jendso/bvaa142. eCollection 2020 Nov 1.
2
Rare Somatic MEN1 Gene Pathogenic Variant in a Patient Affected by Atypical Parathyroid Adenoma.非典型甲状旁腺腺瘤患者中罕见的体细胞MEN1基因致病性变异
Int J Endocrinol. 2020 Apr 27;2020:2080797. doi: 10.1155/2020/2080797. eCollection 2020.
3
Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.
甲状旁腺危象作为非典型甲状旁腺腺瘤的表现:两例诊断难题病例
J Bone Metab. 2022 May;29(2):133-140. doi: 10.11005/jbm.2022.29.2.133. Epub 2022 May 31.
4
Overview of the 2022 WHO Classification of Parathyroid Tumors.《2022 年世卫组织甲状旁腺肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):64-89. doi: 10.1007/s12022-022-09709-1. Epub 2022 Feb 17.
非典型甲状旁腺腺瘤:内分泌肿瘤鉴别诊断中的具有挑战性病变。
Endocr Relat Cancer. 2019 Jul;26(7):R441-R464. doi: 10.1530/ERC-19-0135.
4
A high definition picture of key genes and pathways mutated in pediatric follicular lymphoma.一张关于小儿滤泡性淋巴瘤中发生突变的关键基因和信号通路的高清图片。
Haematologica. 2019 Sep;104(9):e406-e409. doi: 10.3324/haematol.2018.211631. Epub 2019 Feb 28.
5
Molecular genetic insights into sporadic primary hyperparathyroidism.散发性原发性甲状旁腺功能亢进症的分子遗传学研究进展。
Endocr Relat Cancer. 2019 Feb 1;26(2):R53-R72. doi: 10.1530/ERC-18-0304.
6
gene mutation with parathyroid carcinoma: first report of a familial case.甲状旁腺癌的基因突变:首例家族性病例报告
Endocr Connect. 2017 Nov;6(8):886-891. doi: 10.1530/EC-17-0207. Epub 2017 Nov 2.
7
Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.甲状旁腺癌的综合征型和非综合征型的分子遗传学。
Hum Mutat. 2017 Dec;38(12):1621-1648. doi: 10.1002/humu.23337. Epub 2017 Sep 25.
8
Targeting EZH2 in cancer therapy.癌症治疗中靶向EZH2
Curr Opin Oncol. 2017 Sep;29(5):375-381. doi: 10.1097/CCO.0000000000000390.
9
Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.细胞分裂周期73基因缺失的小鼠会发生甲状旁腺和子宫肿瘤:一种甲状旁腺功能亢进-颌骨肿瘤综合征的模型。
Oncogene. 2017 Jul 13;36(28):4025-4036. doi: 10.1038/onc.2017.43. Epub 2017 Mar 13.
10
Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature.MEN1 患者中的甲状旁腺癌和非典型甲状旁腺肿瘤:临床病理挑战。MD 安德森病例系列和文献复习。
Int J Surg. 2016 Jul;31:10-6. doi: 10.1016/j.ijsu.2016.05.035. Epub 2016 May 19.